Business
AstraZeneca moves to start making a profit from its vaccine – Sydney Morning Herald
After looking on as Pfizer and Moderna have made billions of dollars in sales, AstraZeneca is shifting to a for-profit model.
The vaccine isnt yet authorised in the US, after the company missed the window for an emergency authorisation due to the complicated nature of its trial results. Astra is planning to submit the shot for approval to regulators in the first half of next year,…
Continue Reading
-
Business23 hours agoBell Potter names the best ASX tech stocks to buy in FY 2026
-
General21 hours agoThe ABC and Ms Lattouf
-
General20 hours agoHuman remains located, police make arrest in search for Sunbury man Joshua Bishop
-
General18 hours agoNetanyahu denounces report IDF soldiers had orders to shoot Gaza aid-seekers